Obesity is the result of abnormal adipose development and energy metabolism. Using vascular endothelial growth factor (VEGF) B-knockout and inducible VEGF downregulation mouse models, we have shown that VEGFB inactivation caused expansion of white adipose, whitening of brown adipose, an increase in fat accumulation, and a reduction in energy consumption. At the same time, expression of the white adipose-associated genes was increased and brown adipose-associated genes decreased. VEGF repression, in contrast, induced brown adipose expansion and brown adipocyte development in white adipose, increased energy expenditure, upregulated brown adipose-associated genes, and downregulated white adipose-associated genes. When VEGFBknockout and VEGF-repressed mice are crossed together, VEGF and VEGFB can counteractively regulate large numbers of genes and efficiently reverse each other's roles. These genes, under counteractive VEGF and VEGFB regulations, include transcription factors, adhesion molecules, and metabolic enzymes. This balancing role is confirmed by morphologic and functional changes. This study reports that VEGF and VEGFB counteractively regulate adipose development and function in energy metabolism.
O besity affects millions of people regardless of age and gender. Excessive fat accumulation is often associated with various health problems, including insulinresistant type 2 diabetes; cardiovascular, nonalcoholic fatty liver, and gallbladder diseases; and cancers (1) (2) (3) . Energy metabolism happens actively in adipose tissues that are classified as white adipose tissues (WATs) and brown adipose tissues (BATs). WAT is a major tissue for energy storage in the form of triglycerides (TGs) as well as a source for hormonal secretion such as leptin and growth factors like vascular endothelial growth factor (VEGF) (4) (5) (6) (7) . BAT, however, is a tissue that is rich in mitochondria and generates heat by consuming chemical energy. Groundbreaking evidence suggests that BAT plays important roles in human adults and is closely associated with body temperature and body weight (8) . Although the ratio of WAT to BAT is very important in body weight control but also regulation of adipose development, the balance of WAT and BAT and how energy metabolism is controlled genetically with regard to consumption or storage are not well understood.
Another type of adipocyte that has been discovered recently is brown-like in morphology and induced in WAT in response to various conditions (9, 10) . These adipocytes express genes normally functioning in BAT and transform TGs to heat as efficiently as BAT. The energy consumption in this type of adipocyte is associated with reduced body weight and increased insulin sensitivity and may provide a promising therapeutic strategy for treating obesity, diabetes, and cardiovascular disorders.
VEGF, VEGFB, VEGFC, and VEGFD have all been implicated in playing roles in adipose tissues and energy metabolism (11) (12) (13) (14) (15) (16) (17) (18) . For instance, downregulation or overexpression of VEGF in WAT has been reported to increase browning, thermogenesis, and energy expenditure (19, 20) . Our previous study has demonstrated that VEGF repression induces browning of white adipose (19) . Other groups have reported that VEGFB inactivation can reduce fatty acid uptake in heart, muscle, and BAT, leading to excessive accumulation of TGs in WAT (21, 22) . VEGF and VEGFB are both growth factors highly expressed in adipose tissues and are often up-or downregulated under certain conditions. However, how these two growth factors are involved in adipose function is still unclear. Although functional studies of VEGFs on angiogenesis are extensive, studies of their roles in the nonvascular system, including adipose development and energy metabolism, are very limited. Studies on expression and function of VEGF receptors on adipose tissues have indicated potential roles of VEGF and VEGFB (23) .
More and more studies have shown that WAT can be partially or completely converted into BAT-like tissues, but whether BAT can also be converted to WAT-like adipose is not known. Conversion between WAT and BAT and the maintenance of their ratios are very important considerations and deserve further systematic investigation. In this report, inducible VEGF repression and VEGFB deletion mouse models have been used to study adipose differentiation and function. VEGF is downregulated using a tetracycline-regulated gene expression system (24) . VEGFB is inactivated by genomic deletions using CRISPR/Cas9 technology. VEGF and VEGFB-transgenic mice were crossed together to generate double-downregulated mice. Interaction between VEGF and VEGFB was studied at the structural and functional as well as at transcriptional levels by RNA sequencing (RNAseq). Broad counteractive actions between VEGF and VEGFB were identified. Genes with potentially important roles in regulating adipose differentiation and energy metabolism are discussed.
Materials and Methods
All general chemicals were purchased from Sigma-Aldrich (St. Louis, MO) or ShengGong (Shanghai, China). All of the enzymes used for molecular biology were from New England Biolabs (Ipswich, MA) or Takara Biotechnology (Dalian, China).
Animals
Animals were maintained in a clean facility in Northeast Normal University. Mice were kept at 20°C, 50 6 20% relative humidity, with free access to food and water, 12:12-hour light/ dark cycles, and pathogen-free conditions. All procedures were followed from the Guide for the Care and Use of Laboratory Animals from the National Institutes of Health and approved by the Institutional Animal Care and Use Committee of Northeast Normal University (AP2013011). C57BL/6J mice were purchased from Vital River Laboratories (Beijing, China). Mice were anesthetized before sacrificing with 1% pentobarbital at doses of 10 mg/kg.
VEGFB knockout mice
The CRISPR-Cas9 system was used to generate VEGFB deletion (25) . Two single-guide RNAs (sgRNAs) were designed in exons 2 and 4. The sgRNA targeting sequences were subcloned into px330 plasmid (Addgene, Cambridge, MA; gifted from Feng Zhang's laboratory) named px330-VEGFBsg1 and px330-VEGFBsg2. The two target sequences are shown in Fig. 1(a) . The mixture of two plasmids was microinjected at a concentration of 2.5 ng/mL each. Positive VEGFB-knockout founders (VEGFb +/2 ) were identified by polymerase chain reaction (PCR) and sequencing using primers flanking the targeted regions [Fig 1(a) The inducible VEGF repression mouse was generated as previously described (24) . Briefly, four copies of tet operator sequences were inserted into the 5 0 -untranslated region of the VEGF gene (VEGF tetO ). b-Actin-tetR-Krab mice (b-actin-tetRKrab) were made by transgenic microinjection. By crossing two transgenic mice, the double-transgenic mice (VEGF tetO /b-actintetR-Krab) with VEGF under doxycycline regulation were generated. With doxycycline in the feed (200 mg/kg), mice express VEGF and propagate normally. Without doxycycline, all double-transgenic embryos die at embryonic day 10.5 due to heterozygous lethality of the VEGF gene (VEGF Down ). This strain of mice has been registered at the Resource Identification Portal Web site (www.scicrunch.org/resources) as Tg(tetO-Vefga)1Ywz and Tg(Actb-tetR*)19Ywz (RRID: MGI: 6115016 and RRID: MGI:6115015).
Generation of VEGF/VEGFB double-downregulated mice
By consecutive crossing of VEGFb 2/2 knockout mice with VEGF Down mice on doxycycline chow, mice with downregulatable VEGF and VEGFB-knockout allele (VEGF Down / VEGFb +/2 or VEGF Down /VEGFb 2/2 ) were generated. Doxycycline was removed at weaning, and mice were fed regular food for 4 to 6 weeks to fully repress VEGF. 55°C overnight. Tail lysates were diluted and boiled for 15 minutes. PCR was performed at 94°C for 2 minutes followed by 30 cycles of denaturing at 94°C for 30 seconds, annealing at 62°C for 30 seconds, and extension at 72°C for 1 minute. Final extension was at 72°C for 5 minutes and held at 4°C. PCR primers were designed as previously described (19) . mice were mostly used for experiments except where indicated because of easy propagation and no significant differences between these two groups of mice.
Experimental design

Real-time PCR
Total RNAs were extracted from gonadal WAT (gWAT) and scapulae BAT using the TRIzol method following the manufacturer's protocol (Life Technologies, Carlsbad, CA). The complementary DNAs were synthesized using Takara Biotechnology's kit, and real-time PCR was performed using SYBR Green mix (Takara Biotechology). The 18s messenger RNA (mRNA) was used as an internal control. Primers were designed as previously reported (19) .
Histology, 4
0 ,6-diamidino-2-phenylindole staining, and hematoxylin and eosin staining After perfusion using 4% paraformaldehyde, tissues were harvested and fixed according to our previously described method (24 
Glucose and insulin tolerance test
For the glucose tolerance test (GTT), 8-to 12-week-old mice were fasted for 16 hours. Glucose (2 g/kg) was injected intraperitoneally, and tail blood glucose was measured at 0, 15, 30, 60, 90, and 120 minutes using a glucometer. For the insulin tolerance test (ITT), mice were fasted for 4 hours, 0.75 U/kg insulin was injected intraperitoneally, and tail blood glucose was measured at 0, 15, 30, 60, 90, and 120 minutes using a glucometer.
Body temperature, oxygen consumption, and serum TG measurement
The body temperature was measured using an electronic thermometer with a rectal probe. Oxygen consumption was analyzed using a homemade respirator that measures consumption of oxygen by alkaline removal of CO 2 . Serum TGs (sTGs) were measured using the Triglycerides Assay kit from Hui Li (Changchun, China).
RNAseq and gene ontology analysis
Whole-genome gene expression was analyzed using HiSeq2500 (27) . Independent libraries were constructed from WAT and BAT of wild-type, VEGF-repressed, VEGFB-knockout, and VEGF/ VEGFB double-downregulated mice. The raw data were filtered using the FASTX-Toolkit (http://hannonlab.cshl.edu/fastx_toolkit/) (28) to remove adaptor contamination and low-quality reads (Q score of 30 .90%). The average fragment length was 350 bp, and more than 5 Gb clean reads (125-bp end) were obtained from each library. Mus musculus genome (GRCm38) from Ensembl (http://useast.ensembl.org/Mus_musculus/Info/ Index) was used as a reference for corresponding annotation files (gff3). Clean reads were mapped to a mouse genome by using Tophat2 (29) . One mismatch was allowed during the mapping process. Other parameters were set as defaults. Differential expression analysis was performed using Cuff diff, version 2.0.0 (30) . Differentially expressed genes (DEGs) were defined as Q values ,0.05.
Gene ontology (GO) assignments were downloaded from the Mouse Genome Informatics Web site (http://useast.ensembl. org/Mus_musculus/Info/Index). A GO slim file was generated using Blast2go (31) in performing enrichment analysis. GO enrichment was estimated by a hypergeometric test using custom R scripts, and significance (P value) was adjusted by false discovery rate (32) . GO terms with a Q value ,0.05 were regarded as significantly enriched.
Statistical analysis
Data are presented as the mean 6 standard error of the mean. Statistical analysis for two groups was performed using an unpaired t test with R GUI software. Significant differences are indicated with asterisks. One-way analysis of variance in R was used when there were more than two groups. Different letters above bars in the figures signify the differences between means (P , 0.05).
Results
Generation of VEGFB deletion mouse model using CRISPR/Cas9 system Exon 3 is the largest coding exon in VEGFb gene (33) . To completely knock out VEGFB function, two sgRNAs were designed in exons 2 and 4 [ Fig. 1(a) ]. Plasmids expressing two sgRNAs and Cas9 were coinjected into fertilized nuclei. Founder with VEGFB deletion was confirmed by genomic PCR and sequencing [ Fig. 1(b) ]. A total of 502 bp was removed [ Fig. 1(a) ]. Deletion also created a frame shift in coding region that could lead to functional loss as well. Loss of VEGFB full-length mRNA was analyzed by quantitative real-time PCR of heart, skeletal muscle, gWAT, and BAT using primers designed from the deleted regions [ Fig. 1(c) ]. As shown in Fig. 1(c) , full-length VEGFB mRNA is completely lost in the VEGFb 2/2 mouse, whereas it is highly expressed in the wild type. Surprisingly, VEGFB mRNA expression level was dramatically decreased in the mitochondria-rich tissues, more than 90% in heart and skeletal muscle, and more than 70% in BAT with single-allele knockout (VEGFb +/2 ). Only gWAT showed an expected drop (50%): a 49% decrease in one-allele deletion [ Fig. 1(c) ]. Null mice showed complete loss of full-length mRNA in all tissues analyzed [ Fig. 1(c) ].
VEGFB deletion results in WAT expansion, BAT whitening, WAT-associated gene upregulation, and BAT-associated gene downregulation Mice with VEGFB deletion grow bigger than wild-type mice in the same litter [ Fig. 2(a) ]. Volumes of gWAT are also significantly bigger in the knockout compared with wild-type mice [ Fig. 2(a) ]. H&E staining indicated that the size of white adipocyte is much larger from the VEGFB-deleted mouse (VEGFb +/2 and VEGFb 2/2 ) than from wild type [ Fig. 2(b) ]. Average body weight and adipose weight are also heavier with homozygous VEGFB deletion [ Fig. 2(c) ]. The number of cells (numbers of DAPI-stained nucleus) per microscopic field is significantly decreased in VEGFB-deleted WAT and BAT [ Fig. 2(d) ]. The most surprising finding is that WAT-like cells developed in the BAT of the VEGFB-deleted mouse [ Fig. 2(b) ]. Results suggest that increase of body weight is at least partially associated with the increased accumulation of fat in adipocytes. Based on the real-time PCR results, expression of leptin, a WAT-specific marker, is significantly increased in the VEGFB-deleted mouse [ Fig. 2(e) ]. Leptin mRNA level is upregulated by 3.5-fold in both WAT and BAT. BAT-associated genes, at the same time, are all downregulated [ Fig. 2(e) ]. UCP-1, a marker gene in mitochondrial function, is downregulated more than fivefold in WAT and more than 20% in BAT. Cell death-inducing DNA fragmentation factor-like effector-a (CIDEA), which plays important roles in BAT differentiation and thermogenesis, was decreased by 6.7-fold in VEGFb Fig. 4(b) ]. VEGF and VEGFB can effectively reverse each other's roles on adipose morphology and body weight gain. VEGFB knockout upregulated leptin gene expression, a WAT-specific marker, and downregulated BAT-associated genes UCP-1, CIDEA, and PGC-1a in both WAT and BAT [ Fig. 4(c) ]. In contrast, under VEGF repression, these BAT function-associated genes are significantly upregulated, and leptin is dramatically downregulated. Mice are 8-week-old males and females (n $ 3). The same lowercase letters above the bars indicate no significant differences, and different lowercase letters indicate significant differences. WT, wild-type.
By crossing VEGFb
+/2 and VEGF Down mice together (VEGFb +/2 /VEGF Down ), the VEGFB effect is completely reversed by VEGF. In addition, the VEGF effect is partially or completely reversed by VEGFB. These results indicate a balancing action between VEGF and VEGFB in regulating adipose morphology, function, and associated gene expression. Although the VEGF model showed only 40% to 60% repression in BAT and WAT, the counteractive effect against VEGFB is dramatic.
VEGF and VEGFB regulate balance of energy metabolism
As expected, VEGF and VEGFB regulate metabolic functions in adipose tissues. As shown in Fig. 5 , mice with VEGFB deletion have slower blood glucose clearance and lower insulin sensitivity. VEGF-repressed mice, in contrast, have faster glucose clearance and similar insulin sensitivity to the wild-type mice. When VEGF and VEGFB are both downregulated, VEGFB blood glucose and insulin levels were normalized to the levels of wildtype mice [ Fig. 5(a)-5(d) ].
We next evaluated the sTG levels. Serum was prepared from 8-to 12-week-old mice. Fig. 5(e) ]. Similarly, the average body temperature of VEGFB-deleted mice was lower than the body Fig. 2 shows GLUT gene regulation by VEGFB and VEGF/ VEGFB together. GLUT8 in WAT and GLUT4, 5, and 12 in BAT also showed significant interactions. Taken together, knockout of VEGFB caused lower metabolic activity in addition to lower glucose tolerance, lower insulin sensitivity, and higher blood TG content. In contrast, VEGF repression induced higher glucose tolerance, higher insulin sensitivity, and higher metabolic activities. This balancing effect may be partially mediated through upand downregulation of FABPs and FATPs. By crossing VEGF-repressed mice to VEGFB-knockout mice, the VEGFB-induced abnormal effects can be significantly improved.
Many VEGF-and VEGFB-regulated genes are associated with adipose differentiation and energy metabolism Interestingly, we have found that many genes that are counteractively regulated by VEGF and VEGFB are associated with cell differentiation and energy metabolism (Fig. 6) . Interferon regulatory factor 4 (IRF4), for example, was significantly downregulated in VEGFb +/2 mice (Fig. 6) . IRF4 functions as a transcription factor that induces expression of PRDM16 and drives UCP-1 expression through interacting with PGC-1a (34, 35) . One-allele knockout of VEGFB reduced IRF4 expression by about 10-fold, and more than 50% of it can be recovered by VEGF repression. Cold and exercise induce expression of CIDEA, Elovl3, and PGC-1a (10) . These genes are also reversibly regulated by VEGF and VEGFB (Fig. 6 ). In addition, VEGFB dramatically downregulated expression of Car4, Elovl3, Dio2, and Pdk4 in WAT and Acot1, Acot2, Acca1b, Ehhadh, and Hacd2 in BAT. Most of these genes are active players in energy metabolism and regulated by protein acetylation. Expression of all of these genes is significantly reversed by VEGF repression (Fig. 6) .
RNAseq results support counteractive roles of VEGF and VEGFB in adipose tissues
To prove our hypothesis that VEGF and VEGFB counteractively regulate adipose morphology and function, we investigated genome-wide adipose gene expression under VEGF repression, VEGFB inactivation, or downregulation of both. Profiles of both WAT and BAT were analyzed by high-throughput RNAseq. RNAseq allows us to identify all genes and pathways under VEGF and VEGFB regulation. After quality control filtering, we obtained ;56 Gb reads (125 bp, paired end) and about 90% of raw data on average, of which 79.31% was uniquely mapped to the reference genome. From analysis of DEGs under VEGF and VEGFB in WAT and BAT, we found more upregulated genes (VEGF 296 up to 195 down and VEGFB 306 up to 189 down) in WAT and more downregulated genes (VEGF 67 up to 233 down and VEGFB 76 up to 267 down) in BAT (binomial test, P , 0.05; Table 1 ). However, in VEGF and VEGFB double-downregulated mice, there are more downregulated genes in both WAT and BAT (up 215 to down 294 in WAT and up 91 to down 254 in BAT). Significant numbers of genes were switched between VEGF and VEGFB gene regulation. GO analysis showed that more diversified genes are involved in biological processes, including signal transduction, cell proliferation, cell differentiation, and cell death in addition to metabolism processes under VEGF and VEGFB regulation (Fig. 7) . VEGF repression leads to reduction of cell death, whereas VEGFB knockout decreased cell proliferation. Results provided strong evidence that VEGFB and VEGF play important balancing roles in energy metabolism, cell proliferation, and cell survival (Fig. 7) .
Many DEGs and pathways are counteractively regulated by VEGF and VEGFB
To further prove our hypothesis, we compared adipose DEGs and pathways of VEGFb +/2 knockout against Figure 6 . Genes significantly and counteractively regulated by VEGF and VEGFB are associated with metabolism. These genes are identified by RNAseq and validated by real-time PCR. The same lowercase letters above the bars indicate statistically insignificant differences and different lowercase letters indicate statistically significant differences. Acca1b, a propionyl-CoA carboxylase 1b; Acot1, Acyl-CoA thioesterase 1; Acot2, Acyl-CoA thioesterase 2; Car4, carbonic anhydrase 4; Dio2, type II iodothyronine deiodinas; Ehhadh, enoyl-CoA hydratase and 3-hydroxyacyl CoA dehydrogenase; Elovl3, elongation of very long-chain fatty acids protein 3; Hacd2, 3-hydroxyacyl-CoA dehydratase 2; Pdk4, pyruvate dehydrogenase lipoamide kinase isozyme 4, mitochondrial; WT, wild-type.
wild-type and VEGF Down /VEGFb +/2 against VEGFb +/2
( Fig. 8, left panels) . Results indicate that most upregulated DEGs (toward the red side of the heat maps in Fig. 8 ) by VEGFB knockout are returned to wild-type levels (more neutral) or downregulated (toward the blue side of the heat maps in Fig. 8 ) in the double-downregulated mice. Similarly, many DEGs downregulated (toward the blue side of the heat maps in Fig. 8 ) by VEGFB are upregulated or partially recovered in the doubledownregulated mice (toward the red side of the heat maps in Fig. 8 ). The pie charts (Fig. 8) indicate the distribution of VEGFB-regulated pathways and the effect of VEGF on VEGFB. Major altered pathways by VEGFB inactivation, including lipid metabolic processes, are significantly reduced or abolished (Fig. 8 , pie charts and list of pathways at right). Similar results were obtained in WAT and BAT. Results indicate that pathways associated with adipose development and functions are also counteractively regulated by VEGF and VEGFB (Fig. 8,  C1 and C2). Genes significantly enriched under VEGF and VEGFB regulations are associated with metabolic processes, cell differentiation, and cell adhesion (Fig. 8) 
Discussion
To study interaction between VEGF and VEGFB on adipose structure and function, we have generated VEGFB-knockout mice using CRISPR-Cas9 technology. VEGFB knockout leads to morphologic and functional transformation of adipose tissues toward WAT development and expansion, a conversion from energy consumption to storage. Although it has been reported that VEGFB inactivation causes expansion of WAT, there has been no report of VEGFB effect on BAT levels. We have found dramatic effects of VEGFB on BAT development and function. VEGFB knockout induced BAT whitening aside from expansion of WAT. Using our unique and reversible VEGF repression mouse model, we have found that VEGF repression induced conversion of adipose tissues from WAT to BAT development along with increased energy consumption. We have reported this previously (19) and also found further browning of BAT under VEGF repression in this study. The current study indicates that WAT and BAT are mutually interconvertible under VEGF and VEGFB regulation [ Fig. 4(a) ]. BAT-whitening events should be as important as WAT browning, although it is mostly ignored. Slowing down the whitening of BAT process could be another valuable resource in combating obesity. VEGF and VEGFB control the balance of browning and whitening events at molecular and functional levels through a much more complex network.
High-throughput RNAseq provided an ideal way of identifying DEGs in adipose. VEGF and VEGFB counteractively control adipose morphology and functions through up-and downregulation of adipose development-and function-associated genes. VEGF and VEGFB function through their receptors. VEGF receptors and coreceptors neuropilins (NP1 and NP2) are all abundantly expressed in adipose tissues (Supplemental Figs. 3  and 4 ). VEGF and VEGFB share receptors of VEGF receptor (VEGFR) 1 and NP1, and many nonvascular functions have been reported that involve VEGFR1 and NP1 (36) . For example, VEGFB regulates fatty acid transport between adipose and mitochondria-rich tissues through VEGFR1 and NP1 (22) . VEGFB knockout also downregulates VEGFR1 in both adipose tissues (Supplemental Fig. 4) . VEGF repression significantly upregulates VEGFR1 expression in WAT (19) . VEGFB knockoutinduced BAT whitening and VEGF repression-induced browning may both use the VEGFR1 signaling pathway. It would be interesting to see if modulation of VEGFR1 could affect adipose differentiation and metabolic balance. It was recently reported that deletion of VEGFR1 could affect both VEGF and VEGFB signaling (37) .
The effects of VEGF on UCP-1 and PGC-1 expression [ Fig. 4(c) ] are completely reversed by VEGFB. However, VEGF cannot reverse the effect of VEGFB. We think that VEGFB has a much stronger effect on inducing whitening and the ability to downregulation UCP-1 and PGC-1a, as we can see from the evidence that the single-allele knockout has the same effect as the homozygote knockout [ Fig. 2(e) ]. Browning involves BAT differentiation and takes a much longer time under VEGF repression, whereas whitening is simply quick accumulation of lipid in adipose. Adipose tissues express many FABPs, FATPs, and GLUTs (Supplemental Fig. 1 ). VEGFB regulates endothelial expression of FATP3 and FATP4 expression in the heart, muscle, and BAT (22) . Inactivation of VEGFB leads to excessive accumulation of TGs in WAT and weight gain. In addition to many genes involved in adipose differentiation and energy metabolism, genes coding for cell matrix and cell-adhesion molecules like Mucins, Spondin2, THBS1, LoxL1, ADAM12, TIPM4, and SDC4 are also counteractively regulated. Mucins 4 and 15, for mice. Spondin 2 is a cell matrix protein that has an inhibitory effect on cell migration. Knockdown of this gene in cells leads to higher migration ability. Overexpression of this gene in J7 cells leads to lower migration and invasiveness (38) . THBS1, another adhesive glycoprotein, is upregulated by VEGF. These genes may be involved in adipose proliferation and differentiation. As expected, there are also genes that are independently regulated by VEGF or VEGFB. VEGFB regulates expression of many major urinary proteins, including Mup1, 2, 6, 9, 13, 14, and 17 in WAT and Mup6, 9, and 17 in BAT, but VEGF does not have a significant effect on these genes. Mups are involved in regulation of energy expenditure. Genetically induced obese and diabetic mice produce much less of this mRNA than their lean siblings (39) . Mup proteins delivered to the bloodstream lead to increased energy expenditure, physical activity, and body temperature and decrease of glucose intolerance and insulin resistance (40) . These results may partially explain that VEGFB has a much stronger effect on metabolism.
Based on morphologic, functional, and genetic studies, it is likely that two separate processes are involved in the balance of adipose differentiation and energy metabolism under VEGF and VEGFB (Fig. 9) . One is long-term adaptation to constant stimuli, including cold and exercise that causes conversion of WAT to BAT. Another is quick response to heat demand that mobilizes fatty acids in both WAT and BAT and upregulation of mitochondrial function. This dual regulatory system is important in maintaining the balance of energy storage and consumption as well as in environmental adaptation. Understanding these regulatory networks may help to identify new drug targets and clinical treatment.
Conclusion
VEGF and VEGFB regulate balance of adipose differentiation and energy metabolism. Adipose structures and functions are controlled by VEGF and VEGFB through a large number of genes and pathways, including transcription factors, adhesion molecules, and metabolic enzymes. This finding has enormous potential to further our understanding of molecular mechanisms underlining obesity and energy metabolism.
